| Neuroendocrine Carcinoma studied in …STUDIED_INderived10 of 1,533show all (up to 200) |
|---|
| → studied in | NCT01555710Phase 3 · terminated Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) · condition mapped CURATED_BROADER · 1,533 trials mapped (599 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638546Phase 2 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer · condition mapped CURATED_BROADER · 1,533 trials mapped (599 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 1,533 trials mapped (599 active) | — | — | Bladder Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05058651Phase 2/Phase 3 · recruiting Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung · condition mapped CURATED_BROADER · 1,533 trials mapped (599 active) | — | — | Extrapulmonary Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06077500Phase 1 · active not recruiting DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer · condition mapped ALIAS · 1,533 trials mapped (599 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406465Phase 2 · recruiting A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity · condition mapped ALIAS · 1,533 trials mapped (599 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189871Phase 1/Phase 2 · recruiting 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors · condition mapped ALIAS · 1,533 trials mapped (599 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 1,533 trials mapped (599 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07465757Phase 2 · recruiting A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) · condition mapped ALIAS · 1,533 trials mapped (599 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509034Phase 1 · recruiting Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease · condition mapped CURATED_BROADER · 1,533 trials mapped (599 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |